Related Experiment Video
Updated: Apr 26, 2026

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney
Sander A Huisman1, Malgorzata Oklejewicz, Ali R Ahmadi
1Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Abstract:
Circadian clock genes regulate 10-15% of the transcriptome, and might function as tumor suppressor genes. Relatively little is known about the circadian clock in tumors and its effect on surrounding healthy tissues. Therefore, we compared the 24-hr expression levels of key circadian clock genes in liver and kidney of healthy control mice with those of mice bearing C26 colorectal tumor metastases in the liver. Metastases were induced by injection of C26 colorectal carcinoma cells into the spleen. Subsequently, tumor, liver and kidney tissue was collected around the clock to compare circadian rhythmicity. Expression levels of five clock genes (Rev-Erbα, Per1, Per2, Bmal1 and Cry1) and three clock-controlled genes (CCGs; Dbp, p21 and Wee1) were determined by qRT-PCR. Liver and kidney tissue of healthy control mice showed normal 24-hr oscillations of all clock genes and CCGs, consistent with normal circadian rhythmicity. In colorectal liver metastases, however, 24-hr oscillations were completely absent for all clock genes and CCGs except Cry1. Liver and kidney tissue of tumor-bearing mice showed a shift in clock periodicity relative to control mice. In the liver we observed a phase advance, whereas in the kidney the phase was delayed. These data show that hepatic metastases of C26 colon carcinoma with a disrupted circadian rhythm phase shift liver and kidney tissue clocks, which strongly suggests a systemic effect on peripheral clocks. The possibility that tumors may modify peripheral clocks to escape from ordinary circadian rhythms and in this way contribute to fatigue and sleep disorders in cancer patients is discussed.
Insights
Cancerous tumors disrupt the body's internal 24-hour clock, affecting healthy liver and kidney tissues. This disruption may explain fatigue and sleep issues in cancer patients.
Area of Science:
- Chronobiology
- Cancer Biology
- Molecular Biology
Background:
- Circadian clock genes regulate a significant portion of the transcriptome and may act as tumor suppressors.
- The impact of circadian clock disruption within tumors on surrounding healthy tissues is not well understood.
Purpose of the Study:
- To investigate the circadian rhythm of clock genes in liver and kidney tissues of mice with colorectal liver metastases.
- To compare circadian gene expression in healthy tissues versus tumor-affected tissues.
Main Methods:
- Mice were induced with C26 colorectal carcinoma liver metastases.
- Tumor, liver, and kidney tissues were collected over 24 hours.
- Quantitative real-time PCR (qRT-PCR) was used to measure expression levels of key clock genes and clock-controlled genes (CCGs).
Main Results:
- Healthy liver and kidney tissues exhibited normal 24-hour oscillations in clock genes and CCGs.
- Colorectal liver metastases showed a complete absence of 24-hour oscillations for most clock genes and CCGs, except Cry1.
- Tumor-bearing mice displayed altered circadian periodicity in liver (phase advance) and kidney (phase delay) tissues compared to controls.
Conclusions:
- Hepatic metastases disrupt the circadian rhythm in surrounding liver and kidney tissues, indicating a systemic effect on peripheral clocks.
- Tumors may alter peripheral clocks to evade normal circadian regulation, potentially contributing to cancer-related fatigue and sleep disturbances.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Circadian Rhythms and Gene Regulation
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Biological Clocks and Seasonal Responses

